Evidence map›Paper›PMID 34166472›Full record

ArticlePloS one2021

High-throughput sequencing reveals genetic determinants associated with antibiotic resistance in Campylobacter spp. from farm-to-fork.

Shaimaa F Mouftah, José F Cobo-Díaz, Avelino Álvarez-Ordóñez, Menattallah Elserafy, Nehal A Saif, Asmaa Sadat, Ayman El-Shibiny, Mohamed Elhadidy

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
3.8field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. International journal of microbiology · 2026
    Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Occurrence of Florfenicol and Linezolid Resistance and Emergence ofInternational journal of microbiology · 2024
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Editorial: The Role of Environmental Reservoirs inFrontiers in cellular and infection microbiology · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Shaimaa F MouftahBiomedical Sciences Program, University of Science and Technology, Zewail City of Science and Technology, Giza, Egypt.
José F Cobo-DíazDepartment of Food Hygiene and Technology and Institute of Food Science and Technology, Universidad de León, León, Spain.
Avelino Álvarez-OrdóñezDepartment of Food Hygiene and Technology and Institute of Food Science and Technology, Universidad de León, León, Spain.
Menattallah ElserafyBiomedical Sciences Program, University of Science and Technology, Zewail City of Science and Technology, Giza, Egypt.ORCID 0000-0002-0272-8498
Nehal A SaifBiomedical Sciences Program, University of Science and Technology, Zewail City of Science and Technology, Giza, Egypt.
Asmaa SadatDepartment of Bacteriology, Mycology and Immunology, Faculty of Veterinary Medicine, Mansoura University, Mansoura, Egypt.
Ayman El-ShibinyBiomedical Sciences Program, University of Science and Technology, Zewail City of Science and Technology, Giza, Egypt.
Mohamed ElhadidyBiomedical Sciences Program, University of Science and Technology, Zewail City of Science and Technology, Giza, Egypt.ORCID 0000-0002-6153-1302
Zewail City of Science and Technology · EGMansoura University · EGUniversidad de León · ESArish University · EG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Campylobacter species are one of the most common causative agents of gastroenteritis worldwide. Resistance against quinolone and macrolide antimicrobials, the most commonly used therapeutic options, poses a serious risk for campylobacteriosis treatment. Owing to whole genome sequencing advancements for rapid detection of antimicrobial resistance mechanisms, phenotypic and genotypic resistance trends along the "farm-to-fork" continuum can be determined. Here, we examined the resistance trends in 111 Campylobacter isolates (90 C. jejuni and 21 C. coli) recovered from clinical samples, commercial broiler carcasses and dairy products in Cairo, Egypt. Multidrug resistance (MDR) was observed in 10% of the isolates, mostly from C. coli. The prevalence of MDR was the highest in isolates collected from broiler carcasses (13.3%), followed by clinical isolates (10.5%), and finally isolates from dairy products (4%). The highest proportion of antimicrobial resistance in both species was against quinolones (ciprofloxacin and/or nalidixic acid) (68.4%), followed by tetracycline (51.3%), then erythromycin (12.6%) and aminoglycosides (streptomycin and/or gentamicin) (5.4%). Similar resistance rates were observed for quinolones, tetracycline, and erythromycin among isolates recovered from broiler carcasses and clinical samples highlighting the contribution of food of animal sources to human illness. Significant associations between phenotypic resistance and putative gene mutations was observed, with a high prevalence of the gyrA T86I substitution among quinolone resistant isolates, tet(O), tet(W), and tet(32) among tetracycline resistant isolates, and 23S rRNA A2075G and A2074T mutations among erythromycin resistant isolates. Emergence of resistance was attributed to the dissemination of resistance genes among various lineages, with the dominance of distinctive clones. For example, sub-lineages of CC828 in C. coli and CC21 in C. jejuni and the genetically related clonal complexes 'CC206 and CC48' and 'CC464, CC353, CC354, CC574', respectively, propagated across different niches sharing semi-homogenous resistance patterns.

Indexed as

Campylobacter coliCampylobacter jejuniMutationAnimalsAnti-Bacterial AgentsBacterial ProteinsChickensDairy ProductsDrug Resistance, BacterialFarmsFood MicrobiologyHumansMicrobial Sensitivity TestsAnti-Bacterial AgentsBacterial Proteins

Identifiers

PMID34166472
PMCPMC8224912
OpenAlexW3177101282

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.